selected scholarly activity
-
chapters
- Chronic Myeloid Leukemia. 300-304. 2008
-
conferences
- Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD. Bone Marrow Transplantation. 1263-1269. 2018
- SELECTIVE DEPLETION OF ALLOREACTIVE T-CELLS WHILE RETAINING VIRUS-SPECIFIC AND MEMORY T-CELLS FROM HAPLOIDENTICAL DONOR LYMPHOCYTES. Cytotherapy. S65-S65. 2016
- Utilization of anti-inhibitors products and inhibitors status of severe hemophilia patients: 5 years national data from the Canadian hemophilia assessment and resource management system. Journal of Thrombosis and Haemostasis. 362-362. 2015
- Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure. Blood. 4554-4554. 2014
- Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial. Blood. 2014
- Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts. Journal of Thrombosis and Haemostasis. 34-34. 2014
- Assessment of patient preferences and perceived value of the comprehensive interdisciplinary combined hemophilia and orthopedic clinic using a validated questionnaire. Haemophilia. 146-146. 2014
- Factor VII deficiency patients: 5 years factors concentrates utilization trend based on the Canadian Hemophilia Assessment and Resource Management System (CHARMS). Haemophilia. 105-105. 2014
- CD34 CELL DOSE IS CORRELATED WITH HEMATOLOGIC RECOVERY BUT NOT CHRONIC GVHD: RESULTS OF THE CBMTG TRIAL COMPARING G-CSF-MOBILIZED PERIPHERAL BLOOD(G-PB) VS G-CSF STIMULATED BONE MARROW(G-BM) IN SIBLING ALLOGRAFTS FOR HEMATOLOGIC MALIGNANCIES. Bone Marrow Transplantation. S55-S56. 2014
- Investigation of the contribution of von Willebrand factor (VWF) propeptide mutations to type 3 VWD using in vitro cellular studies and patient-derived blood outgrowth endothelial cells (BOEC). Journal of Thrombosis and Haemostasis. 176-176. 2013
- Utilization of FXIII concentrates by FXIII deficiency patients in Canadian hemophilia treatments centers: 10 years national data from the canadian hemophilia assessment and resource management system. Journal of Thrombosis and Haemostasis. 587-587. 2013
- Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes. Blood. 1076-1076. 2012
- The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation. Blood. 4195-4195. 2012
- Low bone mineral density and increased fat mass in boys with severe hemophilia. Haemophilia. 23-23. 2012
- Osteochondral Lesions of the Ankle Joint in Patients with Hemophilia A: A Retrospective Case Series. Haemophilia. 128-128. 2012
- Understanding Health and Treatment Decision-Making among Youth with Hemophilia: A Qualitative Approach. Haemophilia. 207-207. 2012
- What do Canadian men living with hemophilia need to know to facilitate optimal disease management? A mixed methods approach. Haemophilia. 175-175. 2012
- Understanding Health and Treatment Decision-Making among Youth with Severe Hemophilia: a Qualitative Approach. International Journal of Qualitative Methods. 791-792. 2012
- Dosing decisions in severe hemophilia a: can we aim lower? FVIII use in a cohort of Canadian patients in 2009. Journal of Thrombosis and Haemostasis. 681-681. 2011
- First analysis of 10-year trend in national factor concentrates usage in hemophilia: data from the Canadian hemophilia assessment and resource management system. Journal of Thrombosis and Haemostasis. 744-745. 2011
- ADAMTS13 levels may influence the clinical expression of severe hemophilia A. Haemophilia. 27-27. 2010
- Change in bone mineral density in patients with severe hemophilia A and B between the ages of 20 and 50: a pilot study. Haemophilia. 22-22. 2010
- Comprehensive care team approach to bleeding disorder patient care: benefits of team meeting. Haemophilia. 12-12. 2010
- Allogeneic-related stem cell transplantation with reduced-intensity conditioning versus best standard of care in older patients with acute myeloid leukaemia in first complete remission. Interim analysis of a prospective multi center phase III trial. Bone Marrow Transplantation. S57-S57. 2010
- Launch of toll free telephone line. Haemophilia. 132-132. 2008
- The prevalence of patients with inhibitor antibodies in Canadians with hemophilia A and B, with application of a new clinical classification system. Haemophilia. 56-56. 2008
- A Systematic Review and Meta-Analysis of Thalidomide in Patients with Previously Untreated Multiple Myeloma.. Blood. 3570-3570. 2006
- Cyclosporine-Induced Nephrotoxicity and Dose Adjustments in Bone Marrow Transplantation.. Blood. 5233-5233. 2006
- The Use of Erythropoietic Agents in Patients with Non-Myeloid Hematological Malignancies.. Blood. 3338-3338. 2006
- Undetected factor VIII level in a type III von Willebrand disease (vWD) patient masquerading as severe hemophilia. Blood. 104B-104B. 2005
- Preemptive therapy with ganciclovir and short-course intravenous immunoglobulin does not prevent recurrent cytomegalovirus infection (CBMTG-102 study). Transplantation and Cellular Therapy. 91-91. 2005
- Survival of HIV infected individuals with hemophilia after 20 years: From the Canadian Hemophilia Registry.. Blood. 842A-843A. 2004
- Canadian pilot trial of haploidentical donor transplantation.. Blood Cells, Molecules, and Diseases. 181-182. 2004
- Canadian pilot trial of haplo-identical donor transplantation. Transplantation and Cellular Therapy. 38-38. 2004
- A randomized trial in hemophilic patients comparing handheld computers with paper diaries for submission of coagulation factor concentrate infusion data.. Blood. 107B-107B. 2003
- Ganciclovir prophylaxis is associated with delayed neutrophil engraftment in patients undergoing haploidentical transplantation.. Blood. 439B-439B. 2003
- Cardiobacterium hominis endocarditis masquerading as very severe refractory immune thrombocytopenic purpura: Report of a case.. Blood. 83B-84B. 2002
- Severe bleeding problems in patients with acquired delta-storage pool disorder (delta-SPD) due to myelodysplastic and myeloproliferative disorders.. Blood. 689A-690A. 2002
- Vein to vein tracking system for factor concentrates.. Transfusion. 136S-136S. 2002
- Canadian bone marrow transplant group (CBMTG) will use modified perugia protocol for multi-centre pilot study of haplo-identical transplantation. Leukemia. 416-416. 2002
- Complete remission of acute promyelocytic leukemia with ATRA.. Blood. 222B-222B. 2001
- A Canadian randomized study comparing peripheral blood (PB) and bone marrow (BM) in patients undergoing matched sibling transplants for myeloid malignancies.. Blood. 481A-481A. 2000
- Hemochromatosis due to aceruloplasminemia: Treatment of an adult Caucasian.. Blood. 224A-225A. 2000
- Prospective evaluation of early discharge of patients with chemotherapy-induced febrile neutropenia and hematological malignancies.. Blood. 322A-322A. 2000
- A randomized Canadian Bone Marrow Transplant Group study comparing peripheral blood and bone marrow allografts in patients undergoing matched sibling transplants for acute myeloid leukemia, chronic myeloid leukemia and myelodysplasia.. Blood. 163A-163A. 1999
- A randomized trial comparing plasma removal to two types of pre-storage leukoreduction to prevent reactions to platelets.. Blood. 376A-376A. 1999
- Bone marrow versus peripheral blood allografts: An evaluation of the donor experience in a Canadian multicentre randomized trial.. Blood. 163A-163A. 1999
- A randomized trial comparing plasma removal to two types of pre-storage leukoreduction to prevent reactions to platelets. Transfusion. 96S-97S. 1999
- Randomized trial of interferon-α maintenance in myeloma patients responding to melphalan and prednisone (MY-6). Cancer Research, Therapy and Control. 129-131. 1998
- CD34+ t(15;17) APL represents a distinct subgroup associated with CD2+, bcr3 isoform, microgranular morphology, a high white count and a poor prognosis.. Blood. 604A-604A. 1998
- Comparison of the clinical utility of the platelet function analyzer (PFA-100 (TM)) and standard bleeding time in patients with hemostatic disorders.. Blood. 90B-90B. 1998
- Acute reactions to platelets: A new classification and interobserver reliability studies.. Transfusion. 40S-40S. 1998
- Face validity of a new classification for platelet reactions.. Transfusion. 43S-43S. 1998
- The development of a practice guideline for treating newly diagnosed patients with chronic myelocytic leukemia. Leukemia and Lymphoma. 24-26. 1998
- Adenoviral-based gene transfer of two forms of stem cell factor to human bone marrow stromal cells.. Blood. 4609-4609. 1997
- Intramarrow administration of an adenoviral vector expressing canine GM-CSF to alleviate neutropenia in dogs treated with chemotherapy.. Blood. 1062-1062. 1997
- Isolation and characterization of cultured human dendritic cells: A potential target for adenoviral-based gene transfer of tumour peptides.. Blood. 4636-4636. 1997
- Monitoring interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation: A marker of acute graft-versus-host disease. Blood. 1675-1675. 1996
- The loss of factor VIII activity during storage in PVC containers is due to protein adsorption and not proteolytic degradation.. Blood. 2111-2111. 1996
- A comparison of two interventions to prevent platelet reactions.. Transfusion. S185-S185. 1996
- The International Registry of Immune Tolerance: 1994 Update. Vox Sanguinis. 42-46. 1996
- Critical appraisal of interferon therapy for chronic myeloid leukemia.. Blood. 3201-3201. 1995
- SEROPREVALENCE OF ANTI-HEPATITIS-A (HAV) IGG IN CANADIAN PATIENTS WITH HEMOPHILIA. Thrombosis and Haemostasis. 1031-1031. 1995
- EFFECTIVE CYTOKINE GENE-TRANSFER TO BONE-MARROW STROMAL CELLS USING ADENOVIRAL VECTORS. Journal of Cellular Biochemistry. 406-406. 1995
- DAY-6 BONE-MARROW (D6BM) PREDICTS FOR COMPLETE REMISSION (CR) IN ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML). Blood. A303-A303. 1994
- EFFECTIVE CYTOKINE GENE-TRANSFER IN HUMAN LONG-TERM BONE-MARROW CULTURED-CELLS USING ADENOVIRAL VECTORS. Blood. A740-A740. 1994
- 2 EPISODES OF NONCARDIOGENIC PULMONARY-EDEMA IN A PATIENT CAUSED BY THE SAME DONORS BLOOD. Transfusion. S26-S26. 1994
- EFFICACY OF ANTI-D TO IMPROVE PLATELET TRANSFUSION RESPONSE - A RANDOMIZED TRIAL. Blood. A403-A403. 1993
- THROMBOTIC THROMBOCYTOPENIC PURPURA - MECHANISM FOR EFFECTIVENESS OF PLASMAPHORESIS. Clinical Research. A299-A299. 1979
- VALUE OF COMBINING IMPEDANCE PLETHYSMOGRAPHY (IPG) WITH 125I-FIBRINOGEN LEG SCANNING (LEG SCANNING) AS A SCREENING-PROCEDURE IN ORTHOPEDIC AND NON-ORTHOPEDIC PATIENTS. Blood. 271-271. 1977
- IMPEDANCE PLETHYSMOGRAPHY (IPG) AND FIBRINOGEN-I-125 LEG SCANNING (LEG-SCAN) IN DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VENOUS THROMBOSIS (DVT). Circulation. 123-123. 1976
-
journal articles
- Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation. 58:478-490. 2023
- von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells. Journal of Thrombosis and Haemostasis. 20:1599-1609. 2022
- ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. Leukemia. 34:1907-1923. 2020
- Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel. Bone Marrow Transplantation. 55:1093-1102. 2020
- Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis – Authors' reply. The Lancet Haematology. 7:e364-e365. 2020
- Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial. Journal of Clinical Oncology. 38:1463-1473. 2020
- Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study. Transplantation and Cellular Therapy. 26:438-444. 2020
- Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. The Lancet Haematology. 7:e100-e111. 2020
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. Journal of Clinical Oncology. 37:1228-1263. 2019
- Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era. Leukemia Research. 73:67-75. 2018
- CD56 bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- versus -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results. Hematology Journal. 102:1936-1946. 2017
- CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 23:405-411. 2017
- Erratum to “Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study” [Biol Blood Marrow Transplant 2016;22:1410-1415]. Transplantation and Cellular Therapy. 23:534-534. 2017
- Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study. Transplantation and Cellular Therapy. 22:1410-1415. 2016
- Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study. Bone Marrow Transplantation. 51:1019-1021. 2016
- Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells. Blood. 127:3082-3091. 2016
- Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. The Lancet Oncology. 17:164-173. 2016
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report. Transplantation and Cellular Therapy. 21:1343-1359. 2015
- Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach. Haemophilia. 21:180-189. 2015
-
First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from
CHARMS , the Canadian Hemophilia Assessment and Resource Management System. Haemophilia. 20:e251-e259. 2014 - The haemophilia certification system in Canada.. Blood Transfusion. 12 Suppl 3:e531-e541. 2014
-
What should men living with haemophilia need to know? The perspectives of
C anadian men with haemophilia. Haemophilia. 20:219-225. 2014 - What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers. Haemophilia. 19:503-510. 2013
- A Review of Pneumatosis Intestinalis in the Setting of Systemic Cancer Treatments, Including Tyrosine Kinase Inhibitors. Canadian Association of Radiologists Journal. 63:312-317. 2012
- The importance of haemophilia treatment centre administrators in patient care. Haemophilia. 18:e366-e367. 2012
- A study of variations in the reported haemophilia B prevalence around the world. Haemophilia. 18:e91-e94. 2012
- Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Haemophilia. 18:e254-e259. 2012
- Comparing bleed frequency and factor concentrate use between haemophilia A and B patients. Haemophilia. 17:872-874. 2011
- A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 16:20-32. 2010
- Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A. Haemophilia. 15:1258-1261. 2009
- Cardiac surgery in patients with haemophilia B: a case report and review of the literature. Haemophilia. 15:108-113. 2009
- Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia. 15:227-239. 2009
- The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review. Annals of Hematology. 87:961-973. 2008
- A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma. Cancer Treatment Reviews. 34:442-452. 2008
- A case of non‐resolving hemophilia B Leyden in a 42‐year‐old male (F9 promoter + 13 A>G). Journal of Thrombosis and Haemostasis. 6:885-886. 2008
- A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. Haemophilia. 14:281-286. 2008
- Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study. Journal of Thrombosis and Haemostasis. 5:1914-1922. 2007
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia. Haemophilia. 13:518-526. 2007
- Very severe thrombocytopenia and fragmentation hemolysis mimicking thrombotic thrombocytopenic purpura associated with a giant intracardiac vegetation infected with Staphylococcus epidermidis: Role of monocyte procoagulant activity induced by bacterial supernatant. American Journal of Hematology. 82:766-771. 2007
- Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme. Haemophilia. 13:271-278. 2007
- A review of randomized controlled trials comparing the effectiveness of hand held computers with paper methods for data collection. BMC Medical Informatics and Decision Making. 6:23. 2006
- Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. Blood. 108:460-464. 2006
- Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study. Haemophilia. 11:216-226. 2005
- A Prospective, non-randomised phase 1–2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma. Biotechnology Annual Review. 11:381-389. 2005
- A survey of factor prophylaxis in the Canadian haemophilia A population. Haemophilia. 10:679-683. 2004
- Canadian multicenter pilot trial of haploidentical donor transplantation. Blood Cells, Molecules, and Diseases. 33:222-226. 2004
- Comparing hand‐held computers and paper diaries for haemophilia home therapy: a randomized trial. Haemophilia. 10:698-704. 2004
- Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. American Journal of Hematology. 76:373-377. 2004
- An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Transplantation and Cellular Therapy. 10:405-414. 2004
- Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. British Journal of Haematology. 125:613-620. 2004
- Health status and health‐related quality of life associated with von Willebrand disease. American Journal of Hematology. 73:108-114. 2003
- Developing a tracking system for coagulation factor concentrates in southern Ontario. Transfusion. 43:556-562. 2003
- Health status and health‐related quality of life associated with hemophilia. American Journal of Hematology. 71:152-160. 2002
- A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood. 100:1525-1531. 2002
- Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone. British Journal of Haematology. 117:768-768. 2002
- A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets. Transfusion. 42:556-566. 2002
- The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative. ACP journal club. 136:619-619. 2002
- Workshop on haploidentical stem cell transplantation: Chicago, Illinois, USA, 18-19 November 2000. Leukemia. 16:424-426. 2002
- Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease. Thrombosis and Haemostasis. 87:224-230. 2002
- Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.. Hematology Journal. 86:1186-1193. 2001
- CD34‐positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform. American Journal of Hematology. 67:34-41. 2001
- Hemocbromatosbdueto aceruloplasmbnemia: Treatment of an adult caucasian. Blood. 96. 2000
- Phase i-n trial of vacop-b + filgrastim (g-csf) support for hiv-related non-hodgkins lymphoma (nhl). Blood. 96. 2000
- Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin’s lymphoma (NHL): results of a provincial strategy. Bone Marrow Transplantation. 26:859-864. 2000
- Suggestions for the management of factor VIII inhibitors. Haemophilia. 6:52-59. 2000
- Loss of factor VIII activity during storage in PVC containers due to adsorption. Haemophilia. 6:89-92. 2000
- Drug therapy for chronic myeloid leukaemia. Current Oncology. 7:229-241. 2000
- Effect of the Factor V Leiden Mutation on the Clinical Expression of Severe Hemophilia A. Thrombosis and Haemostasis. 83:387-391. 2000
- Radiotherapy to control CNS lymphomatoid granulomatosis: A case report and review of the literature. American Journal of Hematology. 62:239-241. 1999
- A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion. 39:231-238. 1999
- The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation. Bone Marrow Transplantation. 23:45-51. 1999
- The role of fludarabine in intermediate- and high-risk chronic lymphocytic leukaemia. Current Oncology. 6:90-102. 1999
- Use of rituximab in the treatment of lymphoma: An evidence summary. Current Oncology. 6:228-235. 1999
- Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective. Bone Marrow Transplantation. 22:1199-1205. 1998
- Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.. Haemophilia. 4:714-720. 1998
- Causes of death in Canadians with haemophilia 1980–1995. Haemophilia. 4:714-720. 1998
- Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy. Transfusion and Apheresis Science. 19:139-148. 1998
- Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation. Bone Marrow Transplantation. 21:769-773. 1998
- A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of Canada. Thrombosis and Haemostasis. 79:872-875. 1998
- The Development of a Practice Guideline for Treating Newly Diagnosed Patients with Chronic Myelocytic Leukemia. Leukemia and Lymphoma. 30:24-26. 1998
- Intramarrow Cytokine Gene Transfer by Adenoviral Vectors in Dogs. Human gene therapy. Clinical development. 8:545-553. 1997
- Economic evaluation of allogeneic bone marrow transplantation: a rudimentary model to generate estimates for the timely formulation of clinical policy.. Journal of Clinical Oncology. 14:1413-1420. 1996
- Quantifying the Fragility of Galactic Disks in Minor Mergers. The Astrophysical Journal (ApJ). 460:121-121. 1996
- Preface. International Journal of Salt Lake Research. 318:1-1. 1996
- Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 13:2354-2360. 1995
- Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 153:147-157. 1995
- Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 153:19-25. 1995
- The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion. 35:548-551. 1995
- The use of anti‐D to improve post‐transfusion platelet response: a randomized trial. British Journal of Haematology. 89:163-168. 1995
- The Role of the Plasma from Platelet Concentrates in Transfusion Reactions. New England Journal of Medicine. 331:625-628. 1994
- Hepatitis C Infection in Patients With Hemophilia: Results of a National Survey. Transfusion Medicine Reviews. 8:210-217. 1994
- Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.. Bone Marrow Transplantation. 12:405-407. 1993
- B‐cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 85:99-102. 1993
- Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 149:405-408. 1993
- Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.. The BMJ. 306:306-307. 1993
- Absence of thrombin generation during therapy with a highly purified solvent/detergent treated factor IX concentrate. Thrombotic and Haemorrhagic Disorders. 7:45-46. 1993
- Summary of Panel Discussion, First Day. Transfusion Medicine Reviews. 6:263-264. 1992
- A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia. Leukemia Research. 16:159-163. 1992
- 1ST SUCCESSFUL UNRELATED BONE-MARROW TRANSPLANT IN CANADA. Canadian Family Physician. 38:163-165. 1992
- First successful unrelated bone marrow transplant in Canada: A look at the longest surviving recipient.. Canadian Family Physician. 38:163-165. 1992
- Recombinant factor VIII concentrate. The Lancet. 339:61-62. 1992
- Warfarin-Induced Skin Necrosis in 2 Patients with Protein S Deficiency: Successful Reinstatement of Warfarin Therapy. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 22:124-128. 1992
- Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.. Bone Marrow Transplantation. 8:477-487. 1991
- Polymyositis: A manifestation of chronic graft-versus-host disease. Journal of American Academy of Dermatology. 25:560-562. 1991
- Survey of the Canadian hemophilia population.. Canadian Journal of Public Health. 82:127-129. 1991
- Resuscitation of the terminally (Reply III). CANADIAN MEDICAL ASSOCIATION JOURNAL. 142:531-532. 1990
- RESUSCITATION OF THE TERMINALLY ILL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 142:531-531. 1990
- Orthotopic liver transplantation in a patient with combined hemophilia A and B. American Journal of Hematology. 33:136-138. 1990
- Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study. British Journal of Haematology. 71:493-497. 1989
- Carrier detection strategy in haemophilia A: the benefits of combined DNA marker analysis and coagulation testing in sporadic haemophilic families. British Journal of Haematology. 70:321-326. 1988
- The bleeding disorders: current concepts and management.. Canadian Family Physician. 34:2539-2577. 1988
- Prognostic implications of basophil differentiation in chronic myeloid leukemia. American Journal of Hematology. 27:110-114. 1988
- Early Detection of HIV Infection in a Newborn. New England Journal of Medicine. 316:272-273. 1987
- Factor VIII concentrate for hemophilia: comparison of two heat-treated products.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 136:150-152. 1987
- High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.. Journal of Clinical Oncology. 5:75-82. 1987
- Classifying acute leukemia by immunophenotyping: a combined FAB- immunologic classification of AML. Blood. 68:1355-1362. 1986
- High‐dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study. American Journal of Hematology. 23:131-134. 1986
- Cytarabine-induced palmar-plantar erythema. JAMA dermatology. 121:1240b-1241. 1985
- Association of renal failure with lewis incompatibility after allogeneic bone marrow transplantation. American Journal of Medicine. 79:143-146. 1985
- Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup study. American Journal of Hematology. 19:167-176. 1985
- Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.. Journal of the National Cancer Institute. 69:240-241. 1985
- Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. Blood. 65:142-148. 1985
- Factors XI and XII are low in subjects with liver disease. Digestive Diseases and Sciences. 28:967-970. 1983
- The treatment of acute myelocytic leukemia in patients 30 years of age and younger. American Journal of Hematology. 13:189-198. 1982
- Myositis ossificans in hemophilia. Skeletal Radiology. 7:27-31. 1981
- Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood. 58:524-529. 1981
- The reversible binding of vinblastine to platelets: implications for therapy. Blood. 57:431-438. 1981
- The low specificity of postoperative perfusion lung scan defects.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 124:153-158. 1981
- Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood. 56:88-92. 1980
- VENOUS THROMBOSIS - THE PREDICTIVE VALUE OF BLOOD-TESTS. Canadian Journal of Surgery. 23:317-317. 1980
- The value of adding impedance plethysmography to 125I-fibrinogen leg scanning for the detection of deep vein thrombosis in high risk surgical patients: A comparative study between patients undergoing general surgery and hip surgery. Thrombosis Research. 15:227-234. 1979
- Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis.. Circulation. 58:898-902. 1978
- Combined Use of Leg Scanning and Impedance Plethysmography in Suspected Venous Thrombosis. New England Journal of Medicine. 296:1497-1500. 1977
- Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis.. Circulation. 53:696-700. 1976
- Proceedings: Platelet survival, fibrinolytic activity, antithrombin II (AT III) level and fibrinogen survival in venous thromboembolism (VTE).. Thrombosis and Haemostasis. 34:566. 1975
- Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin. Seminars in Vascular Medicine. 2:14-32. 1975
- Lymphoma with hypercalcemia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 111:928-930. 1974
- Hemoglobin abnormalities in neoplastic hematological disorders.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 108:843-847. 1973
- Simple atrophic gastritis and gastric carcinoma. Gut. 12:906-911. 1971